DJIA 16,461.32 0.00 0.00%
NASDAQ 4,382.85 0.00 0.00%
S&P 500 1,945.30 18.19 0.94%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.38 -0.01 (-0.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $5.38 -0.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.53
Previous Close $5.39
Daily Range $5.33 - $5.57
52-Week Range $3.80 - $11.48
Market Cap $2.2B
P/E Ratio -8.38
Dividend (Yield) $0.00 (0.0%)
Volume 3,620,974
Average Daily Volume 6,359,328
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

MannKind: 5 Potential Technosphere Applications

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophi

Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape

Dance until the music stops: Insulin biotech Dance Biopharm withdraws $75 million IPO

The State Of MannKind

MannKind: Technosphere Is The Real Game Changer

MNKD January 2017 Options Begin Trading

See More MNKD News...

MNKD's Top Competitors

MNKD $5.38 (-0.19%)
Current stock: MNKD
AMGN $146.90 (2.27%)
Current stock: AMGN
GILD $106.19 (0.09%)
Current stock: GILD
BIIB $313.76 (1.52%)
Current stock: BIIB